Zyla Life Sciences Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Zyla Life Sciences reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$18.24 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2020-05-14
- Zyla Life Sciences net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2020-03-31 was -$18.24M.
- Zyla Life Sciences net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2018-12-31 was -$19.91M, a 1481.96% decline year-over-year.
- Zyla Life Sciences net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2018-09-30 was -$51.22M.
- Zyla Life Sciences net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2018-06-30 was -$11.96M.
- Zyla Life Sciences net income (loss), including portion attributable to noncontrolling interest for fiscal 2018 was -$95.45M.
- Zyla Life Sciences net income (loss), including portion attributable to noncontrolling interest for fiscal 2017 was -$69.36M.
- Zyla Life Sciences net income (loss), including portion attributable to noncontrolling interest for fiscal 2016 was -$90.63M.
- Zyla Life Sciences net income (loss), including portion attributable to noncontrolling interest for fiscal 2015 was -$57.93M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 1 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 2 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 5 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 8 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 11 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | -$18.24M 10-Q · filed 2020-05-14 | ||||||||
| 2019-12-31 | -$46.64M 10-K · filed 2020-03-26 | ||||||||
| 2019-09-30 | -$40.42M 10-Q · filed 2019-11-14 | ||||||||
| 2019-06-30 | -$30.13M 10-Q · filed 2019-08-13 | ||||||||
| 2019-03-31 | -$10.48M 10-Q · filed 2020-05-14 | ||||||||
| 2019-01-31 | $107.24M 10-Q · filed 2020-05-14 | ||||||||
| 2018-12-31 | -$19.91M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$71.14M derived: sum of 2 quarters · filed 2020-03-26 | -$83.10M derived: sum of 3 quarters · filed 2020-03-26 | -$95.45M 10-K · filed 2020-03-26 | |||||
| 2018-09-30 | -$51.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$63.19M derived: sum of 2 quarters · filed 2019-11-14 | -$75.54M 10-Q · filed 2019-11-14 | -$74.10M derived: sum of 4 quarters · filed 2019-11-14 | |||||
| 2018-06-30 | -$11.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$24.32M 10-Q · filed 2018-08-09 | -$22.88M derived: sum of 3 quarters · filed 2019-03-29 | -$41.82M derived: sum of 4 quarters · filed 2019-03-29 | |||||
| 2018-03-31 | -$12.35M 10-Q · filed 2018-05-10 | -$10.91M derived: sum of 2 quarters · filed 2019-03-29 | -$29.86M derived: sum of 3 quarters · filed 2019-03-29 | -$56.34M derived: sum of 4 quarters · filed 2019-03-29 | |||||
| 2017-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$17.51M derived: sum of 2 quarters · filed 2019-03-29 | -$43.99M derived: sum of 3 quarters · filed 2019-03-29 | -$69.36M 10-K · filed 2019-03-29 | |||||
| 2017-09-30 | -$18.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-19 | -$45.43M derived: sum of 2 quarters · filed 2018-11-19 | -$70.80M 10-Q · filed 2018-11-19 | -$92.17M derived: sum of 4 quarters · filed 2018-11-19 | |||||
| 2017-06-30 | -$26.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$51.85M 10-Q · filed 2018-08-09 | -$73.22M derived: sum of 3 quarters · filed 2018-08-09 | -$100.16M derived: sum of 4 quarters · filed 2018-08-09 | |||||
| 2017-03-31 | -$25.37M 10-Q · filed 2018-05-10 | -$46.74M derived: sum of 2 quarters · filed 2018-05-10 | -$73.68M derived: sum of 3 quarters · filed 2018-05-10 | ||||||
| 2016-12-31 | -$21.37M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$48.31M derived: sum of 2 quarters · filed 2018-03-16 | -$90.63M 10-K · filed 2018-03-16 | ||||||
| 2016-09-30 | -$26.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$69.26M 10-Q · filed 2017-11-08 | |||||||
| 2016-06-30 | -$42.33M 10-Q · filed 2017-08-09 | ||||||||
| 2015-12-31 | -$57.93M 10-K · filed 2018-03-16 |